NEWSAR
Multi-perspective news intelligence
D

donanemab

Event Disaster

Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. Donanemab was developed by Eli Lilly and Company.

Total Coverage:0 articles
Last 7 Days:0
View on Wikipedia →

Coverage Timeline

Key Figures & Locations

Sheona Scales
person•1 mentions
England
location•1 mentions
Alzheimer's disease
event•1 mentions
Alzheimer's Research UK
organization•1 mentions
National Health Service
organization•1 mentions
lecanemab
event•1 mentions
Jeffrey Cummings
person•1 mentions
University of Nevada
organization•1 mentions